Advice
following a resubmission:
glucosamine sulphate (Glusartel®) is not recommended for use within NHS Scotland.
Indication under review: relief of symptoms in mild to moderate osteoarthritis of the knee.
In a placebo- and active-comparator study, glucosamine sulphate 1,500mg once daily was significantly better than placebo in the treatment of symptoms associated with osteoarthritis of the knee.
Overall the submitting company did not present a sufficiently robust clinical and economic analysis to gain acceptance by SMC.
Download detailed advice254KB (PDF)
Medicine details
- Medicine name:
- glucosamine sulphate (Glusartel)
- SMC ID:
- 647/10
- Indication:
- For the relief of symptoms in mild to moderate osteoarthritis of the knee.
- Pharmaceutical company
- HFA Healthcare Ltd
- BNF chapter
- Musculoskeletal and joint diseases
- Submission type
- Resubmission
- Status
- Not recommended
- Date advice published
- 08 August 2011